NDC 50474-983 – Rystiggo

Rozanolixizumab 140 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC50474-983

Product details

Brand name
Rystiggo
Generic name
Rozanolixizumab
Labeler
UCB, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761286
Marketed since
June 14, 2024
Listing expires
December 31, 2027
Pharmacologic class
Neonatal Fc Receptor Blocker

Active ingredients

Uses, dosage, side effects and warnings for Rystiggo →

Package NDC codes (1)

Package NDCDescriptionSince
50474-983-861 VIAL, GLASS in 1 CARTON (50474-983-86) / 6 mL in 1 VIAL, GLASSJul 15, 2024

Other Rystiggo products